Zeitlin Gary A, Maslow Melanie J
Curr Allergy Asthma Rep. 2006 Mar;6(2):163-70. doi: 10.1007/s11882-006-0055-y.
The current epidemic of H5N1 highly pathogenic avian influenza in Southeast Asia raises serious concerns that genetic reassortment will result in the next influenza pandemic. There have been 164 confirmed cases of human infection with avian influenza since 1996. In 2004 alone, there were 45 cases of human H5N1 in Vietnam and Thailand, with a mortality rate over 70%. In addition to the potential public health hazard, the current zoonotic epidemic has caused severe economic losses. Efforts must be concentrated on early detection of bird outbreaks with aggressive culling, quarantines, and disinfection. To prepare for and prevent increased human cases, it is essential to improve detection methods and stockpile effective antivirals. Novel therapeutic modalities, including short, interfering RNAs and new vaccine strategies that use plasmid-based genetic systems offer promise, should a pandemic occur.
目前东南亚地区H5N1高致病性禽流感的流行引发了人们对基因重配将导致下一次流感大流行的严重担忧。自1996年以来,已有164例人感染禽流感的确诊病例。仅在2004年,越南和泰国就有45例人感染H5N1病毒,死亡率超过70%。除了潜在的公共卫生危害外,当前的人畜共患病流行还造成了严重的经济损失。必须集中力量通过积极扑杀、隔离和消毒来尽早发现禽类疫情。为了应对并预防人类感染病例的增加,改进检测方法并储备有效的抗病毒药物至关重要。如果发生大流行,包括短干扰RNA和使用基于质粒的基因系统的新疫苗策略在内的新型治疗方法有望发挥作用。